ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy have?
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy has 96 citations in the OpenAlex counts ScholarIQ stores.
When was ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy published?
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy has 2016 year in the ScholarIQ index.
What is the open-access status of ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy?
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy has diamond oa status in the ScholarIQ index.
What is the DOI of ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy?
The DOI for ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy is on the source record.
What is the PMID of ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy?
The PMID for ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy is on the source record.
What is the OpenAlex record for ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy?
The OpenAlex for ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy is on the source record.